hmmm .. speaking of tools utilized courtesy of a sub

New Post Public Reply Private Reply Replies (2) Message Board
4kids
hmmm .. speaking of tools utilized

courtesy of a sub tier via the vehicle of choice re: OTC stock maniplation

Quote:
This latest pump is well setup.


sure it is >> news today wasn't posted by mgmt .. rather a long doing
DD saw that the 10 year permit had been issued (a week after the
5 year permit issued) which btw has yet to be 8k'd

i'd expect that combined 8k to be filed next week


Quote:
1) On February 19, 2014, JBI, Inc. (the "Company" entered into Subscription Agreements (the "Purchase Agreements" with three investors (the "Purchasers" in connection with a private placement of shares of the Company's common stock and warrants to purchase shares of common stock (the "Warrants". Pursuant to the Purchase Agreements, the Company agreed to sell and issue to the Purchasers an aggregate of 2.4 million shares of its common stock and Warrants to purchase up to an additional 2.4 million shares of its common stock. The closings of the transactions under the Purchase Agreements occurred between February 19 and 24, 2014. The purchase price per share was $0.05 and the gross proceeds to the Company were $120,000. The Warrants have a three year term, and an initial exercise price of $0.10 per share of common stock. The Company granted "piggyback" registration rights under certain circumstances with respect to the shares issued at the closing and the shares issuable upon exercise of the Warrants.


no wonder why *retail* gets fleeced .. try thinking outside of the box
ever play chess? or just *fishin*
i've already covered this previously >> a few of us suspect that
the co. noted via 7.1.14 update may be the beneficiary re: this agreement

sorry to sink your theories >> but this is all about the LT (long term)
it's rather amusing to observe *traders* or trolls try to convince investors
to change sides after years of bogus bs



Quote:
2) Bespoke gets re-involved. In fact for a while they even owned the IR contact. Yes this is the same BeSpoke that received free trading shares illegally from John Bordynuik's children's trust fund. These folks are good at running "campaigns".


so now it's bespoke .. hard to keep track of the *EVOlving* talking points
i think i was accused just last week


Quote:
3) You have to get current on your filings so these restricted shares from February can be converted on August 19-24 to free trading.


yep cause they are just desperate for what .. 7c x 2.4M ($168,000)
you really should be doing some *current* DD


Quote:
4) There is so much baggage with the JBI ticker name that it is hard to run a pump to newbies of the stock. But PTOI carries none of the baggage and is ideal for another pump.


well since the *baggage* originated with the first round of stock orchestration
back in Dec 2009 and P2O is what the company *does* in 2014 .. it's not rocket science
why the name/ticker and cusip would be changed out this year

first hint >> sale of prox

second hint of what is en route .. after BoD is seated >> expect
mgmt to be changed out too .. then uplisting out of the cesspool
will be the *goal*

btw in case memo was missed >> there are *few* newbies on the vehicle of choice re: OTC stock manipulation

even the 4 bagged for money laundering this week .. were PROs
at the ripe old ages of 20 to 25



Quote:
5) Allow some to front-load by leaking "big things are coming" and create excitement. Telegraphing of the announcement begins on smbs. This is the point we are at today.


who parroting?

and using search >> no one but you >> snicker >> posted big things coming

SMBs are passe .. don'cha know .. it's all about *tweets* and the like


Quote:
6)Announce hokey RKT/Heddle Ship/Florida type deal. Let the fake hoopla begin.


nope .. seriously do some DD over this weekend and then buy a clue
but then as i've noted a few x over >> both investors and trolls know
the name

here's to when mgt 8k's it


Quote:
7) Some will genuinely get excited but a massive sell-off into the price and volume spike will occur by those who have been setup so nicely. And all that selling will be blamed on nefarious shorts and boogeyman.


you are kidding right .. do you ever look at quote media to check *volume*

do you understand why PTOI has had 2 of the lowest months re: volume since 2010?

and fyi since this too eludes >> the shorts have a dilemma .. they counted
on being able to *cover* sub 6c .. but they needed actual *legit* shareholders
to SELL

news flash einstein >> it didn't happen .. all who wanted out of PTO
*SOLD* late last year or in January 2014


Quote:
The question for legitimate longs, is this your last best opportunity to sell? Question for those that like to trade will there be enough pop to make it worth trading?


and gee how very non surprising out of a sub tier

when all else fails try to convince folks to sell at the bottom

could you be any more obvious .. rhetorical

sorry to disappoint >> but *investors* bought today >> 105k+

you do the percentage >> if able


4kids

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 8

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
Lymphatic Research Gains Attention Beyond Wellness Claims

Updated Category News Views 371

Ankles leave little clues after a long day: sock grooves, puffiness, that dull heaviness nobody bothers to name. PureHealth Research wants people to look past the usual salt-and-water explanation and consider the lymphatic system, the body’s comparatively unsung network for gathering fluid from tissues and returning it to the bloodstream. Fair enough. This system does...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 283

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 334

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 442

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 247

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
ModuleMD Takes Allergy EHR AI Beyond the Usual Hype Cycle

Updated Category News Views 278

Allergy Workflows Are Where This Has to Earn Its Keep Allergy clinics do not need another shiny dashboard clogging up a workstation. They need less typing, fewer handoffs, cleaner documentation, and fewer administrative chores slipping through the cracks while a packed day keeps moving. That is the practical lens for ModuleMD's ACAAI 2026 presentation in Phoenix: not...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 460

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 522

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 438

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading

Top 5 Most Recently Viewed Articles

HCW Biologics Advances T-Cell Engagers for Solid Tumors

Updated Category News Views 181

HCW Biologics Unveils Innovative Treatments for Solid Tumors HCW Biologics Inc., a clinical-stage biopharmaceutical company, recently announced important developments in its research on second-generation, multi-specific T-cell engagers. These therapies specifically target solid tumors, notably pancreatic cancer, utilizing the company's proprietary TRBC product discovery...

Continue Reading
Highlights of the Upcoming Small Cap Growth Investor Event

Updated Category News Views 56

Overview of the Small Cap Growth Virtual Investor Conference The Small Cap Growth Virtual Investor Conference is set to take place soon, bringing together a diverse group of companies and investors. This exciting virtual event will provide a platform for companies to showcase their offerings to interested investors from various backgrounds. The conference promises an...

Continue Reading
Crexi Auction Performance Highlights Investor Reengagement

Updated Category News Views 286

Introduction to Crexi Auction's 2025 Performance As the landscape of commercial real estate evolves, Crexi Auction stands out with remarkable performance metrics indicating a strong rebound in market confidence. Recent reports highlight a 96% close rate for Crexi Auction during the first half of the year, showcasing a notable 10% year-over-year increase in transaction...

Continue Reading
Digihost and NANO Nuclear Jointly Propel New York's Energy Future

Updated Category News Views 145

Digihost and NANO Nuclear Join Forces for Renewable Energy Digihost Technology Inc. and NANO Nuclear Energy Inc. have united to submit a proposal to the New York State Energy Research and Development Authority (NYSERDA). Their aim? To facilitate the development of cutting-edge, clean energy solutions that will revolutionize New York's energy landscape. This collaboration...

Continue Reading
Syndax Pharmaceuticals (NASDAQ: SNDX) Faces Market Challenges

Updated Category News Views 151

Syndax Pharmaceuticals (NASDAQ: SNDX) and Its Market Journey Syndax Pharmaceuticals Inc. (NASDAQ: SNDX) has recently made headlines as its stock price has fallen to a 52-week low of $12.75. This decline is indicative of the current hurdles the biopharmaceutical company is facing in a challenging market landscape. Investors have noted that the stock is currently in an...

Continue Reading